UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

              Date of Report (date of earliest event reported): June 27, 2005


                               CEL-SCI CORPORATION
                               -------------------
             (Exact name of Registrant as specified in its charter)


     Colorado                           1-11889               84-0916344
--------------------             ------------------        ------------------
(State or other jurisdiction    (Commission File No.)        (IRS Employer
of incorporation)                                          Identification No.)

                              8229 Boone Blvd. #802
                                Vienna, VA 22182
  ----------------------------------------------------------------------------
          (Address of principal executive offices, including Zip Code)


Registrant's telephone number, including area code:    (703) 506-9460
                                                       --------------

                                       N/A
                  ---------------------------------------------
          (Former name or former address if changed since last report)


Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 3.02   Unregistered Sale of Equity Securities

      On July 18, 2005, CEL-SCI sold 1,250,000 shares of its common stock and
375,000 warrants to one investor for $500,000. Each warrant entitles the holder
to purchase one share of CEL-SCI's common stock at a price of $0.65 per share at
any time prior to July 18, 2009.

      The issuance of these securities was exempt under Section 4(2) of the
Securities Act of 1933 as a transaction by an issuer not involving a public
offering. At the time of issuance, the investor that acquired these securities
was fully informed and advised about matters concerning CEL-SCI, including
CEL-SCI's business, financial affairs and other matters. The investor acquired
the securities for its own account. The shares of common stock and warrants are
"restricted" securities as defined in Rule 144 of the Securities and Exchange
Commission. No underwriters were involved with the sale of these securities.



<PAGE>


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Date:  July 19, 2005

                                 CEL-SCI CORPORATION



                                 By:   /s/ Geert R. Kersten
                                      ----------------------------------------
                                      Geert R. Kersten, Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8k7-05.txt", "secsgml_size_bytes": 3592}]
{"company-data": {"conformed-name": "CEL SCI CORP", "cik": "0000725363", "assigned-sic": "2836", "irs-number": "840916344", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11889", "film-number": "05961844"}, "business-address": {"street1": "8229 BOONE BLVD .", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7035069460"}, "mail-address": {"street1": "8229 BOONE BLVD.", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182"}, "former-company": {"former-conformed-name": "INTERLEUKIN 2 INC", "date-changed": "19880317"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

              Date of Report (date of earliest event reported): June 27, 2005

                               CEL-SCI CORPORATION
                               -------------------
             (Exact name of Registrant as specified in its charter)

     Colorado                           1-11889               84-0916344
--------------------             ------------------        ------------------
(State or other jurisdiction    (Commission File No.)        (IRS Employer
of incorporation)                                          Identification No.)

                              8229 Boone Blvd. #802
                                Vienna, VA 22182
  ----------------------------------------------------------------------------
          (Address of principal executive offices, including Zip Code)

Registrant's telephone number, including area code:    (703) 506-9460
                                                       --------------

                                       N/A
                  ---------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))
Item 3.02   Unregistered Sale of Equity Securities

      On July 18, 2005, CEL-SCI sold 1,250,000 shares of its common stock and
375,000 warrants to one investor for $500,000. Each warrant entitles the holder
to purchase one share of CEL-SCI's common stock at a price of $0.65 per share at
any time prior to July 18, 2009.

      The issuance of these securities was exempt under Section 4(2) of the
Securities Act of 1933 as a transaction by an issuer not involving a public
offering. At the time of issuance, the investor that acquired these securities
was fully informed and advised about matters concerning CEL-SCI, including
CEL-SCI's business, financial affairs and other matters. The investor acquired
the securities for its own account. The shares of common stock and warrants are
"restricted" securities as defined in Rule 144 of the Securities and Exchange
Commission. No underwriters were involved with the sale of these securities.
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  July 19, 2005

                                 CEL-SCI CORPORATION

                                 By:   /s/ Geert R. Kersten
                                      ----------------------------------------
                                      Geert R. Kersten, Chief Executive Officer